Vacci-nation: A case study in health and prosperity
Article
Vaccines have been integral to health and prosperity in the last three centuries.
The Covid-19 vaccination has again demonstrated the value of vaccines – to lives, livelihoods, and national prosperity. Despite that success, it is imperative that the UK isn’t complacent: there is still huge room for improvement.
Doing better on vaccines could support population health, NHS system readiness and the economy. The key lesson from the Covid-19 vaccination programme is that an overly individualised approach to vaccine uptake and inequality is fundamentally limited.
On that basis, our policy recommendations explore how we can move ahead on vaccines, by harnessing the role of innovation, a wider range of public institutions, government, and businesses to support equality in access, uptake, and outcomes.
Related items
Transformed by AI: How generative artificial intelligence could affect work in the UK – and how to manage it
Technological change is a good thing. It has brought exponential gains to living standards and is the foundation of modern society. Yet unmanaged technological change has always come with risks and disruptions.Celebrating 20 years of IPPR North
For two decades IPPR North has been at the centre of the debate about how to rebalance England's regions. Here we take stock of how far we have come and the role we have played in shaping the "levelling up" debate.Costing the Rwanda plan
Total payments to Rwanda for removing this cohort of people could range between £1.1 billion and £3.9 billion.